View | NM_000260.4(MYO7A):c.5804T>C (p.Leu1935Pro) | Likely Pathogenic | Usher syndrome | 2024-09-27 | 1.3 | ClinGen Hearing Loss Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for CDH23, COCH, GJB2,
KCNQ4, MYO6, MYO7A, SLC26A4, TECTA and USH2A Version 2 | MYO7A |
View | NM_000260.4(MYO7A):c.5804T>C (p.Leu1935Pro) | Likely Pathogenic | Usher syndrome | 2024-09-27 | 1.2 | ClinGen Hearing Loss Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for CDH23, COCH, GJB2,
KCNQ4, MYO6, MYO7A, SLC26A4, TECTA and USH2A Version 2 | MYO7A |
View | NM_000260.4(MYO7A):c.5804T>C (p.Leu1935Pro) | Likely Pathogenic | Usher syndrome | 2024-09-24 | 1.1 | ClinGen Hearing Loss Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for CDH23, COCH, GJB2,
KCNQ4, MYO6, MYO7A, SLC26A4, TECTA and USH2A Version 2 | MYO7A |
View | NM_000260.4(MYO7A):c.5804T>C (p.Leu1935Pro) | Likely Pathogenic | Usher syndrome | 2020-06-29 | 1.0 | - | MYO7A |